Inhibitor Research Hub

Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • FK866 (APO866): Unraveling NAMPT Inhibition in Cancer Met...

    2026-01-20

    Explore the advanced mechanisms and translational applications of FK866 (APO866), a potent NAMPT inhibitor, in cancer metabolism targeting and vascular aging research. This in-depth analysis offers unique scientific insights and actionable guidance for hematologic cancer research.

  • N1-Methylpseudouridine: Revolutionizing mRNA Translation ...

    2026-01-19

    N1-Methylpseudouridine sets a new benchmark for mRNA translation enhancement, offering researchers superior protein expression with reduced immunogenicity and cytotoxicity. Its integration into advanced workflows enables breakthroughs in disease modeling, including cancer and neurodegenerative research, while providing actionable troubleshooting strategies for optimized results.

482 records 33/33 page Previous First page 上5页 313233